Nivolumab in Esophageal Squamous-Cell Carcinoma. | N Engl J Med;386(20): 1958-1959, 2022 05 19. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Subject descriptor lookup Advanced Search EVID@Easy

Nivolumab in Esophageal Squamous-Cell Carcinoma.

Ozer, Muhammet; Sahin, Ilyas.

Affiliation

Ozer M; Capital Health Regional Medical Center, Trenton, NJ.
Sahin I; University of Florida Health Cancer Center, Gainesville, FL i.sahin@ufl.edu.

N Engl J Med ; 386(20): 1958-1959, 2022 05 19.

Article in En | MEDLINE | ID: mdl-35584166

Subject(s)

Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Esophageal Neoplasms/drug therapy; Esophageal Squamous Cell Carcinoma/drug therapy; Esophageal Squamous Cell Carcinoma/pathology; Humans; Nivolumab/therapeutic use

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Esophageal Neoplasms / Esophageal Squamous Cell Carcinoma Limits: Humans Language: En Journal: N Engl J Med Year: 2022 Document type: Article

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Esophageal Neoplasms / Esophageal Squamous Cell Carcinoma Limits: Humans Language: En Journal: N Engl J Med Year: 2022 Document type: Article